Parallel Advisors’s Aceragen Inc ACGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-58
Closed 3519
2024
Q2
$0 Hold
58
﹤0.01% 3476
2024
Q1
$0 Hold
58
﹤0.01% 3472
2023
Q4
$0 Hold
58
﹤0.01% 3533
2023
Q3
$22 Hold
58
﹤0.01% 3321
2023
Q2
$95 Hold
58
﹤0.01% 3289
2023
Q1
$133 Sell
58
-1
-2% -$5 ﹤0.01% 3314
2022
Q4
$350 Hold
59
﹤0.01% 3101
2022
Q3
$0 Hold
59
﹤0.01% 3606
2022
Q2
$0 Hold
59
﹤0.01% 3468
2022
Q1
$1K Hold
59
﹤0.01% 2898
2021
Q4
$1K Hold
59
﹤0.01% 3011
2021
Q3
$1K Hold
59
﹤0.01% 3006
2021
Q2
$1K Buy
+59
New +$1.19K ﹤0.01% 2883

Parallel Advisors's ACGN Position: Q3 2024 in Review

Parallel Advisors sold out of Aceragen Inc (ACGN) in Q3 2024, closing a stake of 58 shares.

Parallel Advisors first reported a position in ACGN in Q2 2021 and held it in 13 quarters. The position peaked at $1K in Q1 2022. 0 funds tracked by Wall St. Rank hold ACGN as of Q3 2024.

  • Parallel Advisors reported no remaining Aceragen Inc position as of Q3 2024 after selling out during the quarter.
  • Parallel Advisors sold 58 Aceragen Inc shares in Q3 2024.
  • Parallel Advisors first reported a position in Aceragen Inc in Q2 2021 and held it in 13 quarters.
  • Parallel Advisors's Aceragen Inc position peaked at $1K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Aceragen Inc as of Q3 2024.

Based on Parallel Advisors's 13F filing for Q3 2024, filed 13 Nov 2024.